North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Growth by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, and Others) and Type (Hydrogen-predominant SIBO, Methane-predominant SIBO, and Recurrent SIBO)
- Report Date : Sep 2021
- Report Code : TIPRE00025060
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 76
The North America small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to grow from US$ 53,452.06 thousand in 2021 to US$ 73,794.03 thousand by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. Growing prevalence of IBS and SIBO is expected to surge the market growth. Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. The incidences of IBS are increasing at a significant rate across the region. According to a research article, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study’ published by Elsevier Inc. in 2021, the US have a prevalence rate of 5.3%, respectively. The increasing prevalence of IBS across the region is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS. Likewise, SIBO shows similar symptoms to IBS. Technological developments have now allowed the diagnosis of SIBO while diagnosing IBS. Therefore, the prevalence of SIBO is widely understood and reported across the region. For instance, according to an article, ’Small Intestinal Bacterial Overgrowth: A Case-Based Review’ published in the Journal of Patient-Centered Research and Reviews (JPCRR) in November 2015, 30–85% of adult patients with IBS are likely to develop SIBO across the region. Similarly, according to the recent data published in 2020 by the American College of Gastroenterology, ~78% of IBS patients are living with SBIO; hence, it is a predominantly evaluated condition. It is, therefore, estimated that the prevalence of IBS and SIBO will grow significantly in the near future, leading to the increasing diagnosis and eventual North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market growth.
In case of COVID-19, North America is highly affected specially the US. Industrial sectors in the countries such as the US and Canada has experienced disruption in various industries, including healthcare. However, the need for diagnosis and treatment for the COVID positive patients has carried on business cycles in the medical sector. In addition, the rising demand for personal protective equipment has tried to stabilize the business cycle for the healthcare industry. According to an article issued by Harvard Medical School, infectious viral particles can live in the air for three hours. As a result, it can cause patient scheduling obstructions and put others at risk for contracting the virus. For healthcare providers demanding to test for GI-related problems offered by patients, a substitute for in-office breath testing must be granted due to the potential spread of COVID-19 through aerosolization. Unfortunately, the possible aerosolization spread of COVID-19 makes breath testing in-office comparatively unsafe and has been in a bit of a dilemma in the clinic during this pandemic. The small intestinal bacterial overgrowth diagnostics market also witnessed major decline due to lowered number of diagnostic procedures. Substantial focus on management of COVID had direct impact on diagnostics of abdominal conditions such as irritable bowel syndrome, SIBO, and lactose intolerance. In addition, patients showed reluctance for breath and blood tests due to fear of COVID infection. These factors consequently led to adverse impact on North America small intestinal bacterial overgrowth market during the pandemic period. However, the market is expected to witness considerable growth post-pandemic. Certain factors such as rise in prevalence of SIBO and IBS are estimated to show positive impact on market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America small intestinal bacterial overgrowth (SIBO) diagnostics market. The North America small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to grow at a good CAGR during the forecast period. 
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagnosis
- Breath Testing
- 14C Xylose Breath Test
- Hydrogen Breath Tests
- 14C Glycocholic Acid Breath Test
- Malabsorption Tests
- Small Intestine Aspirate and Fluid Culture Test
- Blood Test
- Others
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type
- Hydrogen-predominant SIBO
- Methane-predominant SIBO
- Recurrent SIBO
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country
- US
- Canada
- Mexico
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market -Companies Mentioned
- Aerodiagnostics, LLC.
- Commonwealth Diagnostics International
- DirectLabs, LLC.
- Genova Diagnostics
- Health Associates Medical Group
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- SIBO Diagnostics
- SIBOTest
- Vibrant Wellness
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 53,452.06 thousand |
| Market Size by 2028 | US$ 73,794.03 thousand |
| Global CAGR (2021 - 2028) | 4.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Diagnosis
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future Analytica
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
John Suzuki President and Chief Executive Officer, Board Director, BK TechnologiesReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Aerodiagnostics, LLC.
- Commonwealth Diagnostics International
- DirectLabs, LLC.
- Genova Diagnostics
- Health Associates Medical Group
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- SIBO Diagnostics
- SIBOTest
- Vibrant Wellness
Get Free Sample For